Direktorat Registrasi ObatValid

RISPERIDONE

BPOM Number: GKL2043007510A1
Approved: 15 May 2025
Expiry: 20 March 2030
Form: Tablet

About This Registration

RISPERIDONE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2043007510A1. Its current registration status is Valid, with the licence valid until 20 March 2030. The product is registered to NULAB PHARMACEUTICAL INDONESIA - INDONESIA. BPOM first approved this registration in March 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: newaero
Packaging: DUS, 5 BLISTER @ 10 TABLET
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

NULAB PHARMACEUTICAL INDONESIA - INDONESIA
KOTA TANGERANG
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

NULAB PHARMACEUTICAL INDONESIA - INDONESIA
KOTA TANGERANG
primary
View profile →

Ingredients (1)

RISPERIDONE

Market Intelligence

Owner Portfolio: NULAB PHARMACEUTICAL INDONESIA - INDONESIA holds 163 BPOM registrations
Manufacturer Scale: NULAB PHARMACEUTICAL INDONESIA - INDONESIA produces 163 registered products
Registration Age: Registered for 1 year, 6 months

FDA Cross-Reference

via openFDA

Generic Name: RISPERIDONE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?